What I mean by out of favour is a low turnover not the quality of A40. Same applies to Mark as I got into TAW based on his appointment, before they done any serious lithium discovery.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025